Article Information
PubMed
Published By
History
- Received January 4, 2022
- Revision received March 25, 2022
- Accepted March 30, 2022
- Published online April 18, 2022.
Copyright & Usage
Copyright © 2022 Beerens et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
Author Information
- 1Strathclyde Institute for Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, G4 0RE, United Kingdom
- 2Laboratory of Neural Connectivity, Brain Research Institute, University of Zürich, 8057 Zürich, Switzerland
- 3MSH Medical School Hamburg, Medical University, Institute for Molecular Medicine, 20457 Hamburg, Germany
- Correspondence should be addressed to Csaba Földy at foldy{at}hifo.uzh.ch or Christian Wozny at christian.wozny{at}medicalschool-hamburg.de.
Author contributions
Author contributions: C.F. and C.W. designed research; S.B., J.W., and C.W. performed research; S.B., D.L., and C.W. analyzed data; C.F. and C.W. wrote the paper.
↵* S.B. and J.W. contributed equally to this work.
Disclosures
The authors declare no competing financial interests.
This work was supported by the R&KE International (Global Engagements) Fund, University of Strathclyde, Glasgow, United Kingdom (C.W.), and the Swiss National Science Foundation Grant CRETP3 166815 (to C.F.).
Funding
Swiss National Science Foundation
CRETP3_166815
Other Version
- You are viewing the most recent version of this article.
- previous version (April 18, 2022).
Article usage
In this issue
Transcriptomically-Guided Pharmacological Experiments in Neocortical and Hippocampal NPY-Positive GABAergic Interneurons
